Roche S, Dhand R, Waterfield M D, Courtneidge S A
European Molecular Biology Laboratory, Heidelberg, Germany.
Biochem J. 1994 Aug 1;301 ( Pt 3)(Pt 3):703-11. doi: 10.1042/bj3010703.
The interaction of phosphatidylinositol 3-kinase (PI 3-K) with polyoma-virus middle-T antigen-pp60c-src (mT:cSrc) complexes and with the platelet-derived growth factor (PDGF) receptor has been investigated. Firstly, we undertook reconstitution studies, using proteins derived from a baculovirus expression system. The p110 catalytic subunit of the PI 3-K associated with tyrosine kinases only when complexed with the p85 alpha regulatory subunit. Both p85 alpha and p110 were substrates of the PDGF receptor. In contrast, only the p85 alpha subunit was detectably phosphorylated when PI 3-K was associated with mT:cSrc. Secondly, we studied PI 3-K in mammalian cells. In mT-antigen-transformed NIH-3T3 cells neither p85 alpha nor p110 was phosphorylated on tyrosine residues in vivo, even though p85 alpha was a substrate in kinase assays in vitro. In quiescent NIH-3T3 cells, PI 3-K showed detectable activity in vitro; PDGF stimulation resulted in a rapid and transient association of PI 3-K with the receptor, which was correlated with a transient increase in intrinsic P13-K activity (approx. 2-fold). The activated PDGF receptor phosphorylated p110 in vitro, at one major site. In vivo, PDGF stimulation induced tyrosine phosphorylation of p110 that persisted for at least 1 h after stimulation. Immunodepletion of the PDGF receptor from stimulated cell lysates showed that p110 was released from the receptor in a tyrosine-phosphorylated form. From these results we conclude that (i) the mT:cSrc complex and the PDGF receptor differ in their association with PI 3-K activity, (ii) PDGF receptor appears to activate PI 3-K in vivo both by relocation of the enzyme and by stimulation of its intrinsic activity, and (iii) tyrosine phosphorylation of the p110 subunit by the PDGF receptor may play a role in PI 3-K regulation in some circumstances.
对磷脂酰肌醇3激酶(PI 3-K)与多瘤病毒中T抗原-pp60c-src(mT:cSrc)复合物以及血小板衍生生长因子(PDGF)受体之间的相互作用进行了研究。首先,我们利用杆状病毒表达系统衍生的蛋白质进行了重组研究。PI 3-K的p110催化亚基仅在与p85α调节亚基复合时才与酪氨酸激酶相关联。p85α和p110都是PDGF受体的底物。相比之下,当PI 3-K与mT:cSrc相关联时,只有p85α亚基可检测到磷酸化。其次,我们在哺乳动物细胞中研究了PI 3-K。在mT抗原转化的NIH-3T3细胞中,体内p85α和p110的酪氨酸残基均未磷酸化,尽管p85α在体外激酶测定中是底物。在静止的NIH-3T3细胞中,PI 3-K在体外显示出可检测到的活性;PDGF刺激导致PI 3-K与受体迅速且短暂地结合,这与内在P13-K活性的短暂增加(约2倍)相关。活化的PDGF受体在体外使p110在一个主要位点磷酸化。在体内,PDGF刺激诱导p110的酪氨酸磷酸化,该磷酸化在刺激后至少持续1小时。从刺激的细胞裂解物中免疫去除PDGF受体表明,p110以酪氨酸磷酸化形式从受体中释放出来。从这些结果我们得出结论:(i)mT:cSrc复合物和PDGF受体与PI 3-K活性的结合方式不同;(ii)PDGF受体在体内似乎通过酶的重新定位和其内在活性的刺激来激活PI 3-K;(iii)在某些情况下,PDGF受体对p110亚基的酪氨酸磷酸化可能在PI 3-K调节中起作用。